Another study showed that iPS-RPE cells from AMD patients carrying ARMS2/HTRA1 risk variant showed higher levels of complement and inflammatory proteins than cells from non-AMD donors [135]. This evidence concerns the gene ARMS2 and age-related macular degeneration.